
Palvella Therapeutics (NASDAQ: PVLA)
$45.31
(1.5%)
$0.67
Price as of August 14, 2025, 11:11 a.m. ET
Palvella Therapeutics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Palvella Therapeutics Company Info
Develops and markets an anticalin-brand protein technology
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.